用酸修饰的奇托衍生物作为潜在的抗真菌剂,对抗Valsa Mali
Zhuo Xu1, Bin Wu1, Chunhua Wu1
1Key Laboratory of State Forestry and Grassland Administration on Highly-Efficient Utilization of Forestry Biomass Resources in Southwest China, Southwest forestry University, Kunming, Yunnan 650224, China.
Carbohydrate polymers
|January 22, 2025
概括
奇托桑被烯酸修饰,以制造新的抗真菌剂. 衍生品PCSAA在体外和体内表现出强烈的抗植物真菌病原体活性.
科学领域:
- 材料科学 材料科学 材料科学
- 生物化学 生物化学
- 农业科学 农业科学
背景情况:
- 酸盐 (CS) 是一种具有潜在抗菌性能的天然生物聚合物.
- 研究基托桑的修改,以提高其作为生物抗菌剂的有效性.
- 开发有效和天然的抗真菌剂对农业至关重要.
研究的目的:
- 合成和表征具有增强抗真菌活性的新奇奇桑衍生物.
- 为了研究改性奇托桑对关键植物病原菌的抗真菌功效.
- 评估这些衍生物作为天然生物抗菌剂的潜力.
主要方法:
- 素被烯酸酸 (APA) 修改,以产生衍生品NCSAA,CSAA,PMCSAA和PCSAA.
- 使用FTIR,1H NMR和XRD分析了结构和晶体变异.
- 在体外对V. mali,C. lunata,A. solani,F. oxysporum和F. graminearum的抗真菌活性进行了评估,使用菌生长速度方法.
- 在体内实验中评估了最佳衍生物的治疗和保护作用.
主要成果:
- 在体外,PCSAA对V. mali表现出最显著的抗真菌活性,EC50为38.66μg/mL.
- 显微镜分析 (SEM,TEM) 显示,衍生物破坏真菌细胞超结构,导致细胞含量损失.
- 在体内研究表明,PCSAA在200μg/mL时具有显著的疗效 (79.09%) 和保护作用 (80.93%).
结论:
- 改性素衍生物,特别是PCSAA,对植物病原体表现出强大的抗真菌活性.
- 作用机制涉及破坏真菌细胞完整性.
- 这些发现凸显了改性素作为农业中天然和有效的生物抗菌剂的潜力.
相关概念视频
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


